OTC:IVPR
INSPIRE VETERINARY PARTNERS, INC.
IVPR offers comprehensive veterinary care services including surgery and wellness plans for pets in the competitive US pet health market.
Key Metrics
Investment Thesis
Bull Case
Investors might consider IVPR as a turnaround play if management can successfully reduce operating expenses or expand surgical case volumes to improve margins. The specialized nature of veterinary surgery provides a defensible niche with potential for premium pricing once profitability is restored.
Bear Case
The stock carries extreme risk due to consistent multi-million dollar losses and negative operating cash flow that threatens the company's ability to fund its own growth without constant capital raising. With current liabilities at $18.6M significantly exceeding shareholders' equity of only $1.6M, the balance sheet is fragile and vulnerable to a downturn in pet healthcare spending.
About INSPIRE VETERINARY PARTNERS, INC.
Inspire Veterinary Partners (IVPR) operates within the veterinary services sector, providing clinical care, surgical procedures, and wellness programs to pets across North America. The company focuses on delivering high-quality animal healthcare through a network of partner clinics and direct service locations. Its revenue model is driven by patient visit volumes, surgical cases, and ancillary product sales.
Analysis
Management Discussion
Despite maintaining steady revenue growth from 2023 to 2024, Inspire Veterinary Partners continues to report significant net losses of approximately $14.3M, widening the gap between revenue and operating costs. The cash flow from operations remains deeply negative at -$10.0M, forcing the company to rely on financing activities like share issuances ($5.5M) and revolver proceeds to fund operations.
Industry Overview
The veterinary services industry is experiencing secular growth driven by rising pet ownership rates and increasing per-pet spending on premium care and longevity treatments. However, consolidation trends mean smaller players must differentiate through specialization or cost efficiency to survive against larger competitors.
Financial Statements
Income Statement
Balance Sheet
Cash Flow
| Metric | 2023 | 2024 |
|---|---|---|
| Revenue | $16.7M | $16.6M |
| Cost of Revenue | $0 | $0 |
| Gross Profit | $16.7M | $16.6M |
| Operating Expenses | $23.9M | $25.6M |
| Operating Income | $-7.2M | $-9.0M |
| G&A | $9.5M | $11.4M |
| Stock-Based Comp | — | $23.6K |
| D&A | $1.3M | $1.3M |
| Depreciation | $503.5K | $559.4K |
| Amortization | $749.1K | $778.3K |
| Other OpEx | $14.4M | $14.2M |
| Non-Operating Income | $-7.6M | $-5.2M |
| Interest Income | $21 | $53 |
| Pre-Tax Income | $-14.8M | $-14.3M |
| Income Tax | $0 | $0 |
| Continuing Ops | $-14.8M | $-14.3M |
| Discontinued Ops | $0 | $0 |
| Net Income | $-14.8M | $-14.3M |
| Minority Interest | $0 | $0 |
| Net to Common | $-14.8M | $-14.3M |
| Metric | 2023 | 2024 |
|---|---|---|
| Current Assets | $1.4M | $2.0M |
| Cash & Equivalents | $179.0K | $523.7K |
| Accounts Receivable | $28.6K | $40.7K |
| Inventory | $571.5K | $516.6K |
| Prepaid Expenses | $388.8K | $942.5K |
| Other Current Assets | $184.3K | $0 |
| Long-Term Assets | $20.4M | $18.2M |
| PP&E (Net) | $7.9M | $6.4M |
| Intangibles | $2.5M | $1.6M |
| Goodwill | $8.1M | $8.0M |
| Operating Leases | $1.6M | $1.9M |
| Other LT Assets | $212.9K | $254.0K |
| Total Assets | $21.8M | $20.2M |
| Current Liabilities | $7.6M | $8.2M |
| Accounts Payable | $3.2M | $2.0M |
| Current Leases | $141.7K | $184.0K |
| Other Current Liab | $3.3M | $5.8M |
| Long-Term Liabilities | $15.0M | $10.4M |
| LT Operating Leases | $1.5M | $1.9M |
| Other LT Liab | $13.5M | $8.5M |
| Total Liabilities | $22.6M | $18.6M |
| Shareholders' Equity | $-788.3K | $1.6M |
| Paid-In Capital | $20.4M | $37.9M |
| Retained Earnings | $-21.2M | $-36.4M |
| Total L&E | $21.8M | $20.2M |
| Metric | 2023 | 2024 |
|---|---|---|
| Net Income (CFO) | $-14.8M | $-14.3M |
| Non-Cash Adjustments | $7.8M | $5.9M |
| Working Capital Changes | $3.2M | $-1.6M |
| Cash from Operations | $-3.8M | $-10.0M |
| Capital Expenditures | $383.7K | $238.0K |
| Cash from Investing | $-1.9M | $-238.0K |
| Share Buybacks | — | $650.0K |
| Cash from Financing | $5.6M | $10.6M |
| FX Effect | $0 | $0 |
| Net Change in Cash | $-65.3K | $344.7K |
| Beginning Cash | $444.3K | $379.0K |
| Ending Cash | $379.0K | $723.7K |
Frequently Asked Questions
How does INSPIRE VETERINARY PARTNERS, INC. make money?
The company derives revenue primarily from clinical services (wellness visits, vaccinations, diagnostics), surgical procedures (orthopedics, soft tissue, dermatology), and ancillary income from retail products and insurance partnerships. Recent financials show a total revenue of $16.6M with significant gross profit margins despite high operating expenses.
What are the main risks for IVPR?
The company faces severe profitability challenges with net losses exceeding $14M annually, indicating structural cost issues or insufficient pricing power. High operating expenses of $25.6M against $16.6M in revenue suggest an unsustainable burn rate without significant operational restructuring. Negative cash flow from operations of $10.0M and a substantial retained earnings deficit of $36.4M raise concerns about long-term solvency.
What is IVPR's competitive advantage?
IVPR leverages a specialized network of board-certified surgeons and experienced veterinarians to offer advanced surgical capabilities that general practitioners cannot match. The company benefits from recurring revenue streams through preventive care programs and pet insurance partnerships that stabilize cash flow against volatile surgical demand.
Related Companies
Not financial advice. All content is for informational purposes only. Data may contain errors. Consult a qualified financial advisor before making investment decisions.